|Last Price$44.04||Day Change (%)0.36%|
|Open Price$43.93||Day Change ($)0.16|
|Day Range43.65–44.06||52-Week Range37.24–45.49|
As of Mon 7/25/2016 5:02:00 PM | USD
China's Food and Drug Administration Approves GlaxoSmithKline's Cervarix
United States Sports Drink Market - By Type, Application & Geography - Expected to Reach $1035.2 Million by 2020 - Research and Markets
Dengue Fever Therapeutics Pipeline Review, H1 2016 Edition - Research and Markets
Global Bile Duct Cancer (Cholangiocarcinoma) Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Sanofi, Novartis, Bayer - Research and Markets
RedstoneConnect Wins Extension to Mobile App Pact from GlaxoSmithKline
Global Hepatitis B Pipeline Review H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Abivax, Akshaya Bio, GeneCure - Research and Markets
Global Influenza Vaccine Market Outlook 2022 - Research and Markets
Brexit' Vote Casts Pall Over U.K. Business Plans--2nd Update
The markets took a stream of negative news and weak economic growth indicators in stride during the first quarter.
We've found some intriguing U.K. investment opportunities.